
takeaway sap capit market day
journey right direct continu
multi-product platform strategi track ahead expect
perfect storm event impact year-end book
consolid long overdu
color fundament focu call sap
marzaa demonstr activ hemophilia import unmet
need subq treatment
meet manag reaffirm develop timelin
prepar pipelin event commerci
analyst certif import disclosur see
deliv solid quarter ramp recur revenu
maintain perform valuat
long-term opportun close monet gap vs fb
limit advertis roster weigh near-term growth
datatim feb zayo quarter
zayo better fundament major strateg
reit uncertainti unlik acquir
modest organ growth expect large-compani
 overhang stock
solid stori remain track maintain outperform
pt
set tone solid fundament
limit visibl eps/epsilon keep us sidelin
outsiz spend leg top pick downgrad
evalu close macro climat particularli broader spend trend within understand better sector backdrop
newli expand consum growth e-commerce coverag conclus least consum perspect investor angst
toward potenti mark econom downturn seem overblown despit indic weakish jan certain nearer-term risk
primari underpin better retail sale growth late appear solidli place valuat depress moder
seem discount sustain deceler spend view unlik street forecast well-posit oper
seem accommod lend potenti upsid still healthi backdrop reflect offens postur reiter nike
low top pick lift price target wayfair lower rate oreilli
among chang
takeaway sap capit market day
sap manag provid upbeat set present investor annual capit market day highlight includ driver better
consist possibl upsid upcom report result confid resumpt oper margin growth increas
profit expect acceler growth cash flow bottom line believ sap execut well strategi offer
digit intellig enterpris manag platform stock rebound year busi show better trend qualtric
margin growth resum develop fulli reflect sap valuat given challeng risk effect
restructur organ integr oper technolog product servic thousand qualtric calliduscloud
gigya employe
journey right direct continu
solid result check anoth box ceo mark benjamin near- mid-term goal essenti third consecut quarter
better-than-expect result coupl imag divis sale complet last week see note feel head
right direct target list automot unit spin-off revenue remain track end game
focu effort healthcar revenue enterpris divis well return cash sharehold apples-to-
appl basi exceed revenu ep target rais ep reiter revenu target continu
oper reiter outperform pt
multi-product platform strategi track ahead expect book
report book growth beat top end guidanc midpoint fairli sizabl deal came ahead
expect quarter boost book strong guidanc ahead street-high estim valid
traction compani get multi-product platform strategi omcl multipl product launch start deliv result
larg deal includ multipl product believ transit multi-product platform key differenti posit
compani strateg partner rx solut traction product make us believ higher-than-histor growth
next year increas estim growth reiter outperform rate target
perfect storm event impact year-end book guidanc
vocera much lower expect guidanc big surpris growth deceler bring back memori prolong
weak believ caus book gap appear explain untim government shutdown caus fed busi delay
year-end new smartbadg introduct appear disrupt order flow uncommon addit lumpi
caus intern busi come lower anoth government shutdown could delay fed order standard across va/
dod give us confid order resum eventu believ growth resum mid-teen test time
stick stori retain outperform rate adjust target
report ep well our/consensu oper out-performance segment modestli ahead ebit
expect favor tax rate import manag guid solid l/msd core sale growth hsd includ petersen
contribut significantli favor ccm price/cost continu self-help margin progress across cft cbf
believ pillar thesi strongli intact rise core ccm profit upsid margin/accret potenti accella underappreci
margin expans prospect cft discount balanc sheet option believ sustain ep outgrowth
intermedi term combin outlook discount valuat ebitda reiter outperform rate increas
price target
consolid long overdu
bbt sti announc merger agreement feb opinion exemplifi best merger agreement common
featur bank landscap like deal merger equal though larger
market cap bbt equal two signific geograph overlap gener enough cost save make set
sharehold winner transact thu sti sharehold get premium base last night close bbt share
today rather significantli might case paid big premium sti share write
color fundament focu call sap
marzaa demonstr activ hemophilia import unmet need subq treatment
cbio present import updat eahad meet phase ii marzaa factor viia program updat includ
strong safeti injection-sit reaction dose zero case anti-drug antibodi first demonstr activ
hemophilia patient clinician focu potenti treatment breakthrough bleed hemlibra-tr patient separ data
treatment breakthrough bleed registr studi hemlibra demonstr novoseven recombin factor viia
iv effect treat bleed oral abstract believ data support opportun substitut subcutan marzaa iv
novoseven believ opportun underappreci investor discuss cbio abstract factor ix gene therapi
 full report publish today
meet manag reaffirm develop timelin lifileucel
thursday sat manag discuss recent clinic regulatori progress iovanc tumor infiltr lymphocyt til
therapi expect enrol melanoma patient pivot cohort lifileucel on-going phase trial begin soon irb
approv secur first clinic site registr cohort design enrol patient includ interim analysi
util overal respons rate orr primari endpoint line estim manag anticip complet enrol earli
potenti allow bla file later year expect updat data patient treat cohort well updat
data cervic cancer reiter outperform pt
prepar pipelin event commerci execut
report result adcetri sale royalti line consensu post-approv hl
track commerci execut guidanc adcetri sale consensu approv
unlock addit address popul hl/ptcl popul commun set slower adopt
academ center hl earli adopt revers term catalyst could transform multi-product
compani data two pivot studi data could form basi acceler approv base orr
data tucatinib mbc data
three-year result on-going open-label studi present yesterday worldsymposium support brineura abil provid long-term
treatment benefit patient remain sidelin see base busi slow growth competit
cloud horizon late-stag candid achondroplasia lack visibl pricing/reimburs prospect hemophilia
gene therapi although palynziq earli launch could sourc near-term upsid driven greater expect kuvan convers
believ share range-bound enthusiasm newli launch product late-stag candid off-set develop
commerci concern
post solid result y/i organ revenu growth ep vs our/street
estim organ growth broad-based payment segment grew y/i respect affirm
outlook anticip organ revenu growth call ep line preliminari guidanc
remain attract busi model lt prospect highli enthusiast pend merger fdc
gener signific revenue/cost synergi relat ep accret next five year trade ep
pro forma includ fdc share appear attract reiter outperform rate price target
deliv solid quarter ramp recur revenu subscript model gain traction
non-gaap basi post eps/revenu well ahead consensu transit
model subscript basi continu outpac manag expect recur revenu increas constant
currenc januari appoint oliv ratzesberg presid ceo succeed victor lund transit presid ceo
execut chairman board director on-going transit subscript model time intern invest
remain key variabl impact trajectori compani continu benefit rise import data enterpris
rapidli increas data volum maintain perform rate
fdc report result line preliminari releas concurr merger announc fdc realiz
y/i organic/cc segment revenu growth organic/cc ebitda growth adjust ep fdc
guidanc also line previous announc expect call organic/cc revenu growth organic/cc ebitda growth
ep impli low double-digit growth segment growth trend broadli solid anticip share trade direct
consid pend all-stock merger maintain outperform rate pt
angi report slight revenu miss opco/street y/i marketplac revenu grow y/i vs
weak relat legaci advertis busi y/i vs marketplac servic pro y/i vs prior qtr
reflect challeng sign sp primari reason angi ramp spend servic request y/i vs
prior quarter track suppli bright side revenue/sp y/i highest rate reflect qualiti
match platform ebitda street expect attribut miss model adjust pro-
forma adjust angi/handi deal fy guidanc ebitda opco estim within quarter angi complet
sale felix leader pay-for-cal perform advertis acquir fixd repair home warranti servic compani
close januari ebitda/fcf remain strong convers manag guid ebitda opco/street
expect revenu guidanc impli opco/street despit guid street revenu angi manag
target y/i increas revenu manag strateg goal aggress push sale market
effort side marketplac drive demand pre-pric transact build tool repeat custom usag pursu
addit adjac categori lastli compani announc share repurchas plan would repres float
lower price target light higher spend support deliveri market futur chain integr
maintain outperform rate long-term view around food restaur industri move electron platform deliveri
short term ebitda depress higher spend ebitda/ord improv set strong ebitda growth
y/i model risk higher invest remain long-term payback signific larg chain
look integr singl partner vs accept take-out order multipl vendor see restaur chain announc
platform deal lead compani next month
strong growth continu meaning long-term opportun maintain perform valuat
maintain perform rate valuat despit report anoth strong quarter higher revenu better expect
arpu rel in-lin subscrib metric revenu y/i vs opco/street estim driven
strong continu growth tinder gold record la cart ebitda basic line tinder sub non-tind
opco total na sub miss beat slightli revenu guid street like impact fx ebitda
guid street management expect fy tinder averag sub close y/i vs purchas remain interest
hing us/uk download y/i
long-term opportun close monet gap vs fb limit advertis roster weigh near-term growth
lower target reduc estim maintain outperform rate believ monet gap
larg vs peer lower fb result exceed expect compani provid dau geographi
first time revenu guidanc well expect limit visibl brand advertis season weak qtr expens
guidanc also expect pattern conserv qtrli guidanc stock show-m
stori earn management highlight key object includ health user experi convers around interest news/
sport invest revenu product improv ad platform well user experi
datatim feb zayo quarter cloudi
zayo report improv result infrastructur busi legaci enterpris much weaker importantli zayo break
two separ compani reit convers delay year think sell next year
anoth good quarter gain share improv network continu
manag meet takeaway set strong
cloud
zayo better fundament major strateg reit uncertainti unlik
zayo key metric rebound decemb quarter net book sequenti second-highest total ever
infrastructur organ growth improv last quarter howev allstream got pummel sequenti declin sale
product ramp slowli expect improv zayo unlik separ two separ compani
time reit convers also uncertain hope compani clarifi strategi analyst day march
rais pt gave initi ebitda guidanc high-end opco/street favor
outlook impli normal sales-forc invest higher trivago profit continu market optim offset
cloud homeaway invest see less visibl two guidanc driver trvg/core-ota advertis efficaci therefor rais
ebitda lower-end rang guidanc assum stabl travel trend item monitor continu homeaway on-line
book deceler manag call seo/int headwind attribut bkng/airbnb higher
outreach us vacat market despit homeaway solid core-ota book trend sustain market optim could start
modest organ growth expect large-compani overhang stock
carbonit result guidanc miss consensu consist rate downgrad novemb
expect saas/appl playbook busi struggl weight effect integr larg
compani acquisit per annum sinc street mis-model busi webroot acquisit increas busi
oper complex bottom line believ manag reset street expect focus achiev growth
oper synergi roll-up strategi rather pay acquir anoth larg compani commod market endpoint
secur alreadi complex stori chang new question aris core busi use capit reiter
perform rate
lower estim report thursday dec sales/ep top neg pre-announce consensu
outlook street given raft neg smartphon news past month
dont expect mani surpris qrvo latest cut weak attribut lower handset volum particularli
china oem sale combin gm increas improv mix better volum gm expect
q/q reflect lower volum fab idle/closur see rf content complex increas approach dont
see handset mainstream volum even macro uncertainti flatten smartphon unit on-going semi-cycl
correct keep us sidelin
inevit ethernet automot ee time
emerg technolog servic
report revenue/ep beat street gross margin expans
account posit surpris note manag deliv consist q/q gross margin improv past six
quarter due well known issu handset market march quarter seem bit weaker expect iot divis still need
time recov temporari slowdown smart speaker demand calendar given uncertainti around latter half
believ total sale may still declin y/i brighter side like see meaning pick-up ddic volum
alongsid oper leverag margin expans stabl opex outlook
solid stori remain track maintain outperform
believ continu repres low-risk growth stori give investor abil crown jewel asset bell come
transform expect model gener outsiz earn growth settl double-digit ep growth
thereaft tb put comp despit sluggish industri trend enjoy increment benefit partnership
move forward kfc continu gener reliabl strong unit growth steadi compstore trend ph appear least stabil
overal analysi suggest attract global growth stori remain track outperform thesi
revenu split differ estim consensu op rs line
collect soft sot margin note downsid differenti off-set oper line sot margin reflect mix within diagnost
channel invest support franchise complex product manag expect low point omther
similar effect rs oem dealership program weak hsd culmin soft year vs tough compar custom platform
launch softer vs strong schedul look favor breadth remain weak balanc shade improv
sot us organ top line notabl consist
sustain growth resourc optim
construct telecom pocket-driven sell-off reiter op pt
share thursday temporari soft us telecom spend drove ep result guidanc consensu
time concern look overdon us air pocket present buy opportun ahead anticip could year
upcycl relat infrastructur spend demand recoveri improv absorpt lead cost provid margin cushion
much model adj ebit margin expans y/i alpha integr appear track achiev target synergi
expand wallet share broadband telecom custom trim estim pt believ thesi remain broadli
intact reiter outperform rate
sustain growth resourc optim
set tone solid fundament
beat consensu ep adj ebitda margin expans reiter guidanc view price-l growth
healthi underli volum demand notabl averag yield coupl all-tim low custom churn rate speak
view intern effort strateg increas custom wtp continu industri growth introduc estim
initi assumpt organ growth could prove conserv reflect assess current econom indic
estim see share fairli valu could becom construct upward revis
sustain growth resourc optim
cpst post revenu expect primarili due alloc product slot rental unit time beat bottom-lin
expect via better expect cost manag encourag see cpst contain opex work reduc suppli
chain expens optim manufactur new credit facil believ cpst addit balanc sheet support
give custom supplier confid work toward sustain profit book strong revenu growth clearli take
longer expect materi look addit progress book revenu growth throughout
adjust ep slightli our/street recoveri hardwar servic off-set weak softwar
compani introduc ep guidanc street includ revenu guidanc
call growth organ po declin compani face headwind effort shift softwar sale
limit visibl eps/epsilon keep us sidelin
report core ep vs our/consensu decid includ hf reserv releas
releas note epsilon debt ep contribut deal valu deconstruct tri provid templat investor gaug
impact epsilon proce valu remain entiti post epsilon sale remain sidelin still given low
visibl on-going busi sale price epsilon manag best provid reason amount guidanc admit
time assumpt around sale make model fundament trajectori difficult scenario estim valuat
thu still see stock fairli valu even sell-off
june summit emerg biotechnolog montauk ny
